Clinical Trial Update: MAnnitol for Blood Pressure Stability in HemoDialysis (MAP-HD) [Phase 2, Phase 3]

View source ↗

Summary

MAP-HD is a Phase 2/Phase 3 clinical trial evaluating mannitol to improve blood pressure stability during hemodialysis, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Mannitol (mannitol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Hemodialysis Complication, Hemodynamic Instability | Phase 2, Phase 3 | Status: COMPLETED